Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Lmna gene knockout cell line constructed based on CRISPR/Cas9 technology

A gene knockout and cell line technology, applied in the biological field, can solve problems such as insufficient research and lack of gene knockout cell lines

Inactive Publication Date: 2021-08-20
GUANGXI MEDICAL UNIVERSITY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the research on the relationship between LMNA gene and disease is still insufficient, and there is a lack of corresponding gene knockout cell lines, so it is necessary to provide a cell model of LMNA gene knockout, so as to provide the necessary tools for scientific research

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lmna gene knockout cell line constructed based on CRISPR/Cas9 technology
  • Lmna gene knockout cell line constructed based on CRISPR/Cas9 technology
  • Lmna gene knockout cell line constructed based on CRISPR/Cas9 technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Example 1 Construction of LMNA gene knockout 293T cell line

[0014] (a) Design of gRNA

[0015] to be knocked out LMNA Based on the complete sequence of the gene, the inventors designed two pairs of gRNA primers, which are:

[0016] gRNA7

[0017] CACCGGCACGCAGCTCCTGGAAGGGT (SEQ ID NO. 1),

[0018] AAACACCCTTCCAGGAGCTGCGTGCC (SEQ ID NO. 2), and

[0019] gRNA8

[0020] CACCGGCGCCGTCATGAGACCCGAC (SEQ ID NO. 3),

[0021] AAACGTCGGGTCTCATGACGGCGCC (SEQ ID NO. 4).

[0022] (b) Vector construction

[0023] (b1) Digestion of empty plasmid and gel purification Digest 1ug of plasmid with restriction endonuclease BbsI, 37°C, 30min:

[0024] BBSI 1ul PX459 1ug 10xBbSI buffer 5ul Sterilized water Make up to 50ul

[0025] Plasmids digested with the QIAquick Gel Extraction Kit were gel purified and eluted in EB.

[0026] (b2) Phosphorylation and annealing gRNA reaction system:

[0027] gRNA-F 1ul gRNA-R 1ul 10x...

Embodiment 2

[0052] Construction of the HePG2 cell line of embodiment 2 LMNA gene knockout

[0053] (a) gRNA primer design

[0054] Based on the complete sequence of the lmna gene to be knocked out, the inventors designed two pairs of gRNA primers, which are:

[0055] gRNA 5

[0056] CACCGGTTCCGCCAGCAGCCGCCGGC (SEQ ID NO. 7),

[0057] AAACGCCGGCGGCTGCTGGCGGAACC (SEQ ID NO. 8); and

[0058] gRNA 6

[0059] CACCGGAGCGGGAGATGGCCGAGATG (SEQ ID NO. 9),

[0060] AAACCATCTCGGCCATCTCCCGCTCC (SEQ ID NO. 10).

[0061] (b) Vector construction

[0062] (b1) Digestion of empty plasmid and gel purification Digest 1ug of plasmid with restriction endonuclease BbsI, 37°C, 30min:

[0063] BBSI 1ul PX459 1ug 10xBbSI buffer 5ul Sterilized water Make up to 50ul

[0064] Plasmids digested with the QIAquick Gel Extraction Kit were gel purified and eluted in EB.

[0065] (b2) Phosphorylation and annealing gRNA reaction system:

[0066] gRNA-F 1ul gR...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a LMNA gene knockout cell line, the cell line is a 293T cell line or a HePG2 tumor cell line. The cell line is based on the crispr-cas9 technology and utilizes two pairs of gRNAs shown in SEQ ID NO.1-4 or two pairs of gRNAs shown in SEQ ID NO.7-10 to construct plasmid vectors to transfect cells to be knocked out. Resistance screened. The LMNA gene knockout cell line can be used for screening cell models for disease intervention drugs such as dilated heart disease, lipodystrophy syndrome, progeria syndrome and the like.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a LMNA gene knockout cell line constructed based on CRISPR / Cas9 technology and a construction method thereof. Background technique [0002] The CRISPR / Cas9 genome-directed editing technology developed in recent years can achieve specific and precise knockout of the genome. Genome-directed editing techniques can result in deletions, insertions, or substitutions of targeted loci. Following ZFN and TALEN technologies, the CRISPR / Cas9 system has rapidly developed into the 3rd generation genome editing technology. The CRISPR / Cas9 system is transformed from the CRISPR / Cas system II. Compared with ZFN and TALEN technologies, the CRISPR / Cas9 system is very simple in design, synthesis and screening, and it is easy to operate, low in cost, short in construction period, and can edit multiple genes at the same time, doubling the improvement of gene Editing efficiency. [0003] The LMNA gene ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/90C12N5/10C12N15/85C12R1/91
CPCC12N5/0693C12N15/85C12N15/907C12N2510/00C12N2800/80C12N2810/10
Inventor 舒伟刘恒杨晓波李东明李福记朱兰玉
Owner GUANGXI MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com